Institutional
August 9, 2017
Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes
Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.
In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com
Back
Share:
Last related news
January 31, 2025
Kasznar Leonardos is recognized by Lexology Legal Influencers Q4 2024
We are honored to announce that Kasznar Leonardos has been recognized as a leading firm in Intellectual Property in South and Central … Kasznar Leonardos is recognized by Lexology Legal Influencers Q4 2024
January 30, 2025
Elisabeth Kasznar will be at 2025 The Business of Trade Secrets Conference
Explore Global Legal Trends! Our partner Elisabeth Kasznar Fekete is a project team member for The Business of Trade Secrets: Navigating the … Elisabeth Kasznar will be at 2025 The Business of Trade Secrets Conference
January 29, 2025
Kasznar Leonardos is ranked in WTR 1000 2025
We are honored to announce that we have been ranked as a reference firm in the field of Trademarks, within the gold … Kasznar Leonardos is ranked in WTR 1000 2025